Bergeron-Lynn G - Search Results

1

Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.

Kuppermann BD, Assil KK, Vuong C, Besen G, Wiley CA, De Clercq E, Bergeron-Lynn G, Connor JD, Pursley M, Munguia D, Freeman WR. Kuppermann BD, et al. J Infect Dis. 1996 Jan;173(1):18-23. doi: 10.1093/infdis/173.1.18. J Infect Dis. 1996. PMID: 8537656

2

Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis.

Arevalo JF, Gonzalez C, Capparelli EV, Kirsch LS, Garcia RF, Quiceno JI, Connor JD, Gambertoglio J, Bergeron-Lynn G, Freeman WR. Arevalo JF, et al. J Infect Dis. 1995 Oct;172(4):951-6. doi: 10.1093/infdis/172.4.951. J Infect Dis. 1995. PMID: 7561215

3

Absence of infectious retinitis after injection of human cytomegalovirus into rabbit eyes.

Tatebayashi M, Neyts J, Besen G, Flores-Aguilar M, Smith IL, Wiley CA, Spector SA, Bergeron-Lynn G, Maudgal PC, De Clercq E, et al. Tatebayashi M, et al. J Infect Dis. 1995 Apr;171(4):782-7. doi: 10.1093/infdis/171.4.782. J Infect Dis. 1995. PMID: 7706803

4

Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.

Besen G, Flores-Aguilar M, Assil KK, Kupperman BD, Gangan P, Pursley M, Munguia D, Vuong C, De Clercq E, Bergeron-Lynn G, et al. Besen G, et al. Arch Ophthalmol. 1995 May;113(5):661-8. doi: 10.1001/archopht.1995.01100050129042. Arch Ophthalmol. 1995. PMID: 7748139

5

Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

Flores-Aguilar M, Huang JS, Wiley CA, De Clercq E, Vuong C, Bergeron-Lynn G, Chandler B, Munguia D, Freeman WR. Flores-Aguilar M, et al. J Infect Dis. 1994 Mar;169(3):642-7. doi: 10.1093/infdis/169.3.642. J Infect Dis. 1994. PMID: 8158041

6

An animal model of focal, subacute, viral retinitis.

Freeman WR, Schneiderman TE, Wiley CA, Listhaus AD, Svendsen P, Munguia D, Bergeron-Lynn G. Freeman WR, et al. Retina. 1993;13(3):214-21. doi: 10.1097/00006982-199313030-00005. Retina. 1993. PMID: 8235102

7

Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMP.

Shakiba S, Assil KK, Listhaus AD, Munguia D, Flores-Aguilar M, Vuong C, Wiley CA, Tolman RL, Karkas JD, Bergeron-Lynn G, et al. Shakiba S, et al. Invest Ophthalmol Vis Sci. 1993 Sep;34(10):2903-10. Invest Ophthalmol Vis Sci. 1993. PMID: 8395482

8

An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.

Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores-Aguilar M, Munguia D, Bergeron-Lynn G, De Clercq E, Keefe K, Freeman WR. Taskintuna I, et al. Exp Eye Res. 1997 May;64(5):795-806. doi: 10.1006/exer.1996.0273. Exp Eye Res. 1997. PMID: 9245910

9

Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.

Dolnak DR, Munguia D, Wiley CA, De Clercq E, Bergeron-Lynn GL, Boscher C, Connor JD, Sherwood C, Capparelli E, Armani R, et al. Dolnak DR, et al. Invest Ophthalmol Vis Sci. 1992 Apr;33(5):1557-63. Invest Ophthalmol Vis Sci. 1992. PMID: 1559752

10

Intraocular tolerance of perfluorooctylbromide (perflubron).

Flores-Aguilar M, Munguia D, Loeb E, Crapotta JA, Vuong C, Shakiba S, Bergeron-Lynn G, Wiley CA, Weers J, Freeman WR. Flores-Aguilar M, et al. Retina. 1995;15(1):3-13. Retina. 1995. PMID: 7754245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters